menu search

ADVB / IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan

IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan
Advanced Biomed has filed proposed terms for a $112 million U.S. IPO. The firm is developing a portfolio of cancer screening technologies for the Chinese market. ADVB has no revenue history, significant operating risks, is thinly capitalized and is seeking a high valuation at the IPO. Read More
Posted: Jul 19 2023, 13:25
Author Name: Seeking Alpha
Views: 050916

ADVB News  

IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan

By Seeking Alpha
July 19, 2023

IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan

Advanced Biomed has filed proposed terms for a $112 million U.S. IPO. The firm is developing a portfolio of cancer screening technologies for the Chin more_horizontal

Advanced Biomed Begins $150 Million U.S. IPO Rollout

By Seeking Alpha
May 23, 2023

Advanced Biomed Begins $150 Million U.S. IPO Rollout

Advanced Biomed has filed to raise $150 million in a U.S. IPO, although the final amount may vary. The Taiwan-based firm is developing various diagnos more_horizontal

Advanced Biomed to raise $150M in IPO

By Proactive Investors
May 23, 2023

Advanced Biomed to raise $150M in IPO

Advanced Biomed, a Taiwan-based diagnostics developer, is planning to raise up to $150 million in an initial public offering (IPO).  The company said more_horizontal


Search within

Pages Search Results: